Lowan Stewart is the founder and medical director of Axon Clinics, and a board member of Axon Research Foundation. He is a specialist in emergency medicine (MD) with more than 20 years of clinical experience.

Stewart founded Insight Ketamine in New Mexico in 2016 and helped build Scandinavia’s first public ketamine unit at Østfold Hospital. In 2018 he founded Axon Clinics, which today operates two clinics and has delivered several thousand treatments.

He is a co-founder of the Norwegian Association for Psychedelic Science and of NorRAD, the Norwegian network for rapid-acting antidepressants. Research from this network underpinned Norway becoming, in 2025, the first country in the world to grant public reimbursement for ketamine treatment. That same year he received the Pioneer Award at the Nordic Psychedelic Awards.